Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 2
2011 2
2012 3
2013 2
2014 3
2015 3
2016 5
2017 3
2018 3
2019 4
2020 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapy in hepatocellular carcinoma.
Buonaguro L, Mauriello A, Cavalluzzo B, Petrizzo A, Tagliamonte M. Buonaguro L, et al. Among authors: petrizzo a. Ann Hepatol. 2019 Mar-Apr;18(2):291-297. doi: 10.1016/j.aohep.2019.04.003. Epub 2019 Apr 25. Ann Hepatol. 2019. PMID: 31047849 Free article. Review.
Combinatorial immunotherapy strategies for hepatocellular carcinoma.
Tagliamonte M, Petrizzo A, Tornesello ML, Ciliberto G, Buonaguro FM, Buonaguro L. Tagliamonte M, et al. Among authors: petrizzo a. Curr Opin Immunol. 2016 Apr;39:103-13. doi: 10.1016/j.coi.2016.01.005. Epub 2016 Feb 4. Curr Opin Immunol. 2016. PMID: 26851637 Review.
Antigen-specific vaccines for cancer treatment.
Tagliamonte M, Petrizzo A, Tornesello ML, Buonaguro FM, Buonaguro L. Tagliamonte M, et al. Among authors: petrizzo a. Hum Vaccin Immunother. 2014;10(11):3332-46. doi: 10.4161/21645515.2014.973317. Hum Vaccin Immunother. 2014. PMID: 25483639 Free PMC article. Review.
Cellular prognostic markers in hepatocellular carcinoma.
Buonaguro L, Tagliamonte M, Petrizzo A, Damiano E, Tornesello ML, Buonaguro FM. Buonaguro L, et al. Among authors: petrizzo a. Future Oncol. 2015;11(11):1591-8. doi: 10.2217/fon.15.39. Future Oncol. 2015. PMID: 26043213 Review.
Systems vaccinology for cancer vaccine development.
Petrizzo A, Tagliamonte M, Tornesello M, Buonaguro FM, Buonaguro L. Petrizzo A, et al. Expert Rev Vaccines. 2014 Jun;13(6):711-9. doi: 10.1586/14760584.2014.913484. Epub 2014 Apr 28. Expert Rev Vaccines. 2014. PMID: 24766452 Review.
Translating tumor antigens into cancer vaccines.
Buonaguro L, Petrizzo A, Tornesello ML, Buonaguro FM. Buonaguro L, et al. Among authors: petrizzo a. Clin Vaccine Immunol. 2011 Jan;18(1):23-34. doi: 10.1128/CVI.00286-10. Epub 2010 Nov 3. Clin Vaccine Immunol. 2011. PMID: 21048000 Free PMC article. Review.
Challenges in cancer vaccine development for hepatocellular carcinoma.
Buonaguro L, Petrizzo A, Tagliamonte M, Tornesello ML, Buonaguro FM. Buonaguro L, et al. Among authors: petrizzo a. J Hepatol. 2013 Oct;59(4):897-903. doi: 10.1016/j.jhep.2013.05.031. Epub 2013 May 25. J Hepatol. 2013. PMID: 23714157 Free article. Review.
29 results